Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Dyadic and Fermbox Bio Expand Strategic Collaboration to Accelerate Commercialization of Animal-Free Proteins and Enzymes Across Life Science, Food & Nutrition, and Bioindustrial Markets
-
Dyadic and Fermbox Bio Expand Strategic Collaboration to Accelerate Commercialization of Animal-Free Proteins and Enzymes Across Life Science, Food & Nutrition, and Bioindustrial Markets
-
AZI Plans to Subscribe for US$100 Million of Token Cat Limited Shares at US$30 per Share, Strengthening Automotive Group-Buying Channels and Supporting AZI’s Global Expansion Strategy
-
Wallbridge Announces its 2026 Exploration Program and Budget
-
ExGen Signs Binding LOI to Acquire Silver Stream on Past-Producing Gold Mine
-
MADD Canada Urges Canadians to Plan Ahead and Drive Sober This Holiday Season
-
Lifecore Biomedical Signs CDMO Master Services Agreement with New Large Multinational Pharmaceutical Customer
-
Abcourt Presents Operations Update for November 2025 in the Development of the Sleeping Giant Mine
-
Abaxx Calls Warrants, Provides Corporate Update
-
Xali Gold to Close First Tranche of Private Placement December 19, 2025
-
Secura Bio Announces NCCN® Duvelisib (COPIKTRA®) Update to Clinical Practice Guidelines in Oncology for Cutaneous T-Cell Lymphoma (CTCL), Including Mycosis Fungoides and Sézary Syndrome
-
Landmark Study Shows Combination of Castle Biosciences' DecisionDx®-UM and PRAME Outperforms Gene Mutation Analysis in Predicting Survival Outcomes in Uveal Melanoma
-
EyePoint to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Tango Therapeutics to Participate in 44th Annual J.P. Morgan Healthcare Conference
-
Akamai and Visa Join Forces to Secure the Next Era of Agentic Commerce
-
Addition Therapeutics Announces $100 Million in Funding and Significant Progress Advancing Mission to Fulfill Promise of Genomic Medicine for Chronic and Rare Diseases
-
Simply Good Foods to Report First Quarter Fiscal Year 2026 Financial Results on Thursday, January 8, 2026
-
Nuvectis Pharma Announces the Initiation of the Phase 1b Study of NXP900 in Combination with Osimertinib in Patients with NSCLC
-
New Book Helps Close the Leadership Gap in Crisis Readiness
-
Bitcoin Munari Confirms Final Presale at $0.015 With No Further Rounds Planned
-
Department of Energy Mandates Centralia Unit 2 Remain Available for Operation for 90 Days
-
Mutuum Finance (MUTM) Advances Through Roadmap Phase 2 with Phase 6 99% Allocated and over $19.4M Raised
-
Sol-Gel Provides Update Following Unblinding of Phase 1b Study of SGT-210 in Darier Disease
-
Biomea Fusion to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Higher Customer Spend: How the Best Hospitality Venues Get It Right with Music and Onscreen Entertainment with Orange Door Music Video Inc.
-
PyroGenesis Signs Contract Toward the Use of Plasma in the Treatment of Low-Level Radioactive Waste
-
NevGold Adds 6 Square Kilometers of Highly Prospective Outcropping Antimony-Gold Targets at Limo Butte, Nevada
-
Bombardier Announces Notice of Partial Redemption for US$500,000,000 of its 6.000% Senior Notes due 2028
-
4DMT Announces Positive Interim Clinical Data from 4D-710 AEROW Phase 1 Clinical Trial in Cystic Fibrosis Lung Disease
-
Axogen, Inc. to Participate in the J.P. Morgan 2026 Healthcare Conference
-
ONAR Holding Newly Acquired ‘JUICE’ Marketing Team, Achieves Record Black Friday Results on All Metrics, Exceeds Volume Targets By 300%+
-
TTEC Digital Named a Leader and Star Performer in Everest Group’s 2025 PEAK Matrix® for Mid-market Digital Transformation Services
-
Coder and GlobalLogic Partner to Accelerate AI Development in the Enterprise
-
Sagimet Biosciences and TAPI Announce Global License Agreement for Innovative Forms of Resmetirom API for Sagimet’s Fixed Dose Combination Program
-
OTC Markets Group Welcomes Cabral Gold Inc. to OTCQX
-
Landmark Study Shows Combination of Castle Biosciences' DecisionDx®-UM and PRAME Outperforms Gene Mutation Analysis in Predicting Survival Outcomes in Uveal Melanoma
-
Baker Hughes to Supply Advanced Artificial Lift Solutions to Enhance Production in Kuwait Oil Company Fields
-
Entrada Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Faridoxorubicin (AVA6000) Phase 1b cohort demonstrates clinically meaningful tumor shrinkage in patients with salivary gland cancers
-
CMR Surgical secures 510(k) clearance of its Versius Plus robotic surgical system
-
ABM Reports Fourth Quarter and Full Fiscal 2025 Results and Provides Fiscal 2026 Outlook
-
ABM Expands Semiconductor and Technical Services Platform with Agreement to Acquire WGNSTAR
-
YieldMax® ETFs Announces Weekly Distributions for Group 2 ETFs
-
FundFi Merchant Funding Expands with New Alabama Office
-
Bitget Wallet Launches Rewards Hub for Onchain Tasks and Programs
-
Form 8.3 Unite Group plc
-
Global Specialty Chemicals Leader Chooses Kneat for Digital Validation
-
Form 8.3 Idox
-
Form 8.3 Empiric Student Property Plc
-
Form 8.3 Bluefield Solar Income Fund Ltd
